



Stockholm, Sweden - May 24, 2017 -  Karin Bernadotte, member of the board of
ContextVision AB, has purchased 2 000 shares in ContextVision AB.

On May 23(rd) 2017 Karin Bernadotte purchased 2 000 shares at an average price
of NOK 58,00. Following this transaction Karin Bernadotte owns 8 500 shares in
ContextVision AB.

"ContextVision has started to develop in a new direction and I see a great
potential for future growth" comments Karin Bernadotte.

For inquires please contact CEO Anita Tollstadius;
anita.tollstadius@contextvision.se

                                      ---
                              About ContextVision
ContextVision is a medical technology company specializing in image analysis and
 artificial intelligence. Its cutting-edge technology helps doctors accurately
    interpret medical images, a crucial foundation for better diagnosis and
   treatment. As an industry pioneer for more than 30 years, ContextVision is
     taking a leading position within deep learning, the latest artificial
 intelligence technology. ContextVision is currently investing significantly in
    the field to expand its product portfolio. The present product portfolio
 includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound,
  MRI, X-ray and mammography which is used by leading equipment manufacturers
    worldwide. ContextVision is based in Sweden and listed on the Oslo Stock
       Exchange under the ticker COV. For more information, please visit
                         http://www.contextvision.com.



 
    